%0 Journal Article
%T Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab
%A Abhishek Kavati
%A Ashok Vegesna
%A Benjamin Ortiz
%A Bradd Schiffman
%A Brandee Paknis
%A Brian Stone
%A Dominic Pilon
%A Maryia Zhdanava
%A Patrick Lefebvre
%J Archive of "Allergy & Rhinology".
%D 2018
%R 10.1177/2152656718763387
%X Indication of omalizumab in the United States was recently extended to include pediatric (6¨C11 years) uncontrolled moderate-to-severe allergic asthma patients
%K allergic asthma
%K moderate-to-severe asthma
%K uncontrolled asthma
%K omalizumab
%K anti-immunoglobulin E antibody
%K biologic
%K pediatric asthma
%K electronic medical records
%K baseline characteristics
%K clinical profile
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028162/